Search alternatives:
significant limitations » significant implications (Expand Search), significant variations (Expand Search), significant variation (Expand Search)
mean decrease » a decrease (Expand Search)
include » included (Expand Search)
significant limitations » significant implications (Expand Search), significant variations (Expand Search), significant variation (Expand Search)
mean decrease » a decrease (Expand Search)
include » included (Expand Search)
-
1
-
2
-
3
-
4
-
5
SUI-sEVs decreased the proliferation of fibroblasts.
Published 2021“…(B) The percentage of proliferative fibroblasts in three groups. SUI-sEVs significantly decreased the proliferation of fibroblasts after 72h when compared to the cells in control group and treated with the non SUI-sEVs. …”
-
6
-
7
-
8
-
9
-
10
-
11
-
12
SUI-sEVs decreased the migration ability of primary cultured fibroblasts.
Published 2021“…(B) The variation of scratching space between groups is shown in the line chart. SUI-sEVs significant decreased the migration ability of primary cultured fibroblasts at 48h when compared to the cells in control group and treated with the non SUI-sEVs. …”
-
13
-
14
-
15
Key safety measures including adverse events.
Published 2025“…Waist circumference (mean change (MC) −2.23 cm; 95% CI [−3.98, −0.49]; <i>p</i> = 0.01), BMI (MC −0.49 kg/m<sup>2</sup>; 95% CI [−0.88, −0.10[; <i>p</i> = 0.01), and android fat mass measured by DXA (MC −167 g; 95% CI [−264, −71[; <i>p</i> < 0.001) decreased in the COCP group over the study period whilst there was no statistically significant changes in these parameters in the metformin only group when compared to baseline.. …”
-
16
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
17
-
18
-
19
-
20